https://doi.org/10.1007/s10549-023-06872-9
G
Gianpiero Rizzo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
19
Papers
58
Citations
3
h-index
2
i10-index
Gianpiero Rizzo is an academic researcher from University of Pavia. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Advanced Breast Cancer Therapies & Breast Cancer Treatment Studies. The author has an h-index of 3, co-authored 17 publications.
Papers by this author
worksConcordance of immunohistochemistry for predictive and prognostic factors in breast cancer between biopsy and surgical excision: a single-centre experience and review of the literature
2023 · Breast Cancer Research and Treatment · 22 citations
SGLT2i Dapagliflozin in primary prevention of chemotherapy induced cardiotoxicity in breast cancer patients treated with neo-adjuvant anthracycline-based chemotherapy +/- trastuzumab: rationale and design of the multicenter PROTECT trial
2025 · Cardio-Oncology · 2 citations
https://doi.org/10.1186/s40959-025-00368-9
1560P Optimal age versus real age in breast and gynaecological risk reducing surgery in BRCA1/2 carriers
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.08.1622
309P Prognostic and predictive value of lobular tumor histology in advanced HR+/HER2- breast cancer treated with ET plus CDK4/6i: A sub-analysis of the PALMARES-2 study
2025 · ESMO Open · 0 citations
https://doi.org/10.1016/j.esmoop.2025.104881
498P Impact of estrogen receptor expression on real-world effectiveness of first-line ET+CDK4/6i in patients with HR+/HER2- advanced BC
2025 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2025.08.921
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat